V021-2290 Screening compound: N~1~-{2-[(2-furylmethyl)amino]-2-oxo-1-[1-(2-phenylacetyl)-4-piperidyl]ethyl}-4-methylbenzamide

V021-2290 Screening compound: N~1~-{2-[(2-furylmethyl)amino]-2-oxo-1-[1-(2-phenylacetyl)-4-piperidyl]ethyl}-4-methylbenzamide
V021-2290 Screening compound: N~1~-{2-[(2-furylmethyl)amino]-2-oxo-1-[1-(2-phenylacetyl)-4-piperidyl]ethyl}-4-methylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V021-2290
N~1~-{2-[(2-furylmethyl)amino]-2-oxo-1-[1-(2-phenylacetyl)-4-piperidyl]ethyl}-4-methylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V021-2290

Molecular Formula

C28H31N3O4 (C28 H31 N3 O4)

Compound Name

N~1~-{2-[(2-furylmethyl)amino]-2-oxo-1-[1-(2-phenylacetyl)-4-piperidyl]ethyl}-4-methylbenzamide

IUPAC name

N-[(furan-2-yl)methyl]-2-[(4-methylphenyl)formamido]-2-[1-(2-phenylacetyl)piperidin-4-yl]acetamide

SMILES

Cc(cc1)ccc1C(NC(C(CC1)CCN1C(Cc1ccccc1)=O)C(NCc1ccco1)=O)=O

InChI

InChI=1S/C28H31N3O4/c1-20-9-11-23(12-10-20)27(33)30-26(28(34)29-19-24-8-5-17-35-24)22-13-15-31(16-14-22)25(32)18-21-6-3-2-4-7-21/h2-12,17,22,26H,13-16,18-19H2,1H3,(H,29,34)(H,30,33)/t26-/m0/s1

InChI Key

IECMOMQVADSDBI-SANMLTNESA-N

MDL Number (MFCD)

MFCD19875660

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

473.57

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.742

Distribution Coefficient, logD

3.742

Water Solubility, LogSw

-3.99

Polar Surface Area

72.287

Acid Dissociation Constant (pKa)

11.84

Base Dissociation Constant (pKb)

4.79

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

32.10

V021-2290 in Drug Discovery

Included in Screening Libraries

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V021-2290 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V021-2290?
Check Price and Availability of V021-2290, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V021-2290 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V021-2290
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V021-2290
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V021-2290 available by request